# ARCANGELO (itAlian pRospective Study on CANGrELOr)

> **NCT04471870** · — · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 1005 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04471870
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-23
- **Primary completion:** 2022-01-17
- **Final completion:** 2022-01-17
- **Target enrollment:** 1005 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04471870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04471870, "ARCANGELO (itAlian pRospective Study on CANGrELOr)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04471870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*